Get the Stockscreener App
7.37
1.60%
-0.12
Lifecore Biomedical Inc stock is traded at $7.37, with a volume of 172.05K.
It is down -1.60% in the last 24 hours and up +11.16% over the past month.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
See More
Previous Close:
$7.49
Open:
$7.55
24h Volume:
172.05K
Relative Volume:
1.01
Market Cap:
$275.91M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
147.40
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
-6.59%
1M Performance:
+11.16%
6M Performance:
+11.16%
1Y Performance:
-1.47%
1-Day Range:
$7.28
$7.63
1-Week Range:
$7.28
$8.11
52-Week Range:
$4.76
$8.85
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Name
Lifecore Biomedical Inc
Sector
Phone
(952) 368-4300
Address
3515 LYMAN BOULEVARD, CHASKA
Compare LFCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
7.37 | 280.62M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-21-25 | Initiated | William Blair | Outperform |
| Sep-05-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Mar-20-23 | Downgrade | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Stock (LFCR) Latest News
Lifecore Biomedical at Stephens Annual Investment Conference: Strategic Growth Path By Investing.com - Investing.com Canada
Can Lifecore Biomedical Inc. stock surprise with earnings upsideQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Will Lifecore Biomedical Inc. stock benefit from green energy trendsProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Is Lifecore Biomedical Inc. stock ready for breakoutStop Loss & Short-Term High Return Strategies - newser.com
What candlestick patterns are forming on Lifecore Biomedical Inc.July 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Should I hold or sell Lifecore Biomedical Inc. stock in 2025July 2025 Recap & Capital Protection Trade Alerts - newser.com
How to interpret RSI for Lifecore Biomedical Inc. stock2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
How Lifecore Biomedical Inc. stock benefits from strong dollarMarket Rally & Expert-Curated Trade Recommendations - newser.com
Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockBull Run & Technical Confirmation Trade Alerts - newser.com
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulation - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Lifecore Biomedical at Jefferies London: Strategic Growth Unveiled By Investing.com - Investing.com Canada
Lifecore Biomedical, Inc. Announces Fiscal Year Change and Strategic Developments - TradingView
Real time pattern detection on Lifecore Biomedical Inc. stockQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesQuarterly Market Summary & Risk Managed Investment Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical (NASDAQ:LFCR) Adds US$54m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 19% - 富途牛牛
Market reaction to Lifecore Biomedical Inc.’s recent news2025 Sector Review & Safe Entry Point Alerts - newser.com
Is it too late to sell Lifecore Biomedical Inc.Market Growth Review & Capital Protection Trading Alerts - newser.com
Is Lifecore Biomedical Inc. stock affected by interest rate hikesMarket Activity Report & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará
Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionWeekly Loss Report & Consistent Return Strategy Ideas - newser.com
Will Lifecore Biomedical Inc. (LDE) stock recover faster than industryQuarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Lifecore Biomedical Inc Stock (LFCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):